Recent Advances in Soft Tissue Tumor Pathology: Evolving Classification, Novel Molecular Findings and New Diagnostic Markers - webinar

Recent Advances in Soft Tissue Tumor Pathology Evolving Classification, Novel Molecular Findings and New Diagnostic Markers is organized by United States and Canadian Academy of Pathology (USCAP) and will be held from Jan 08, 2019 - Dec 06, 2021.

Target Audience:
Practicing academic and community pathologists, and pathologists-in-training

Continuing Medical Education and Continuing Certification:
The United States and Canadian Academy of Pathology designates this enduring material for a maximum of 11.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

The USCAP is approved by the American Board of Pathology (ABP) to offer Self-Assessment credits (SAMs) for the purpose of meeting the ABP requirements for Continuing Certification (CC). Registrants must take and pass the post-test in order to claim SAMs credit. Physicians can earn a maximum of 11.25 SAM credit hours.

Course Description:
The diagnosis of soft tissue tumors can be a significant challenge (even for experienced pathologists) because of their rarity, the broad morphological spectrum of mesenchymal tumors, and overlap with other soft tissue tumors and non-mesenchymal neoplasms. The classification of soft tissue tumors continues to evolve, following the description of “new” tumor types, the discovery of novel molecular genetic alterations, and the development of increasingly specific diagnostic immunohistochemical markers. If your specialty interest is in soft tissue pathology, or if your practice requires enhanced competency in evaluating soft tissue lesions, this course is designed to familiarize you with recently-described soft tissue tumors and recently-developed diagnostic markers. 

Learning Objectives:
Upon completion of this educational activity, learners will be able to:
• Develop a differential diagnosis for soft tissue tumors based on dominant histologic patterns and anatomic sites
• Apply immunohistochemistry to help resolve the differential diagnosis
• Understand the role of molecular genetic testing for the diagnosis of soft tissue tumors

Additional details will be posted as soon as they are available.